EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway

Yang Wang, Ge Gao, Xiangpin Wei, Yang Zhang, Jian Yu

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s405450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Yang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Ch…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansAnimalsMiceTemozolomidebeta CateninWnt Signaling PathwayUbiquitin-Conjugating EnzymesCell Line, TumorDrug Resistance, NeoplasmXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticCell Proliferation

Stichwörter der Autor:innen

UBE2TWnt/β-catenindrug resistanceglioblastomatemozolomide

Substanzen

Temozolomidebeta CateninUbiquitin-Conjugating EnzymesUBE2T protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.

Zitieren

APA

Wang, Y., Gao, G., Wei, X., Zhang, Y., & Yu, J. (2023). UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s405450

Vancouver

Wang Y, Gao G, Wei X, Zhang Y, Yu J. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s405450

BibTeX
@article{Wang2023,
  author = {Wang, Yang and Gao, Ge and Wei, Xiangpin and Zhang, Yang and Yu, Jian},
  title = {UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s405450}
}
Kostenlos starten →